HCRT and isolated hemihyperplasia: The current gold standard for measuring CSF orexin-A is a polyclonal radioimmunoassay (RIA) that differentiates individuals with NT1 from healthy controls, individuals with narcolepsy type 2 (NT2), and idiopathic hypersomnia (IH) (Mignot E, 2002).